Bosnalijek d.d. Sarajevo Logo

Bosnalijek d.d. Sarajevo

Develops, manufactures, and exports a wide range of pharmaceutical products.

BSNL | SASE

Overview

Corporate Details

ISIN(s):
BABSNLR00005
LEI:
Country:
Bosnia and Herzegovina
Address:
Jukićeva 53, 71000 Sarajevo

Description

Established in 1951, Bosnalijek is a pharmaceutical company that develops and manufactures a wide range of medicines. Its portfolio includes products for oral, parenteral, and topical administration, with therapeutic effects on the digestive system, metabolism, and cardiovascular system, among others. The company operates a quality assurance system that is fully compliant with international Good Manufacturing Practice (GMP) standards. Bosnalijek has a significant international footprint, exporting its products to numerous markets across multiple continents. The organization focuses on modernizing its facilities, advancing scientific knowledge, and investing in new technologies to drive innovation within the pharmaceutical sector.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Bosnalijek d.d. Sarajevo filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bosnalijek d.d. Sarajevo

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bosnalijek d.d. Sarajevo via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AVACTA GROUP PLC Logo
Clinical-stage biotech developing targeted oncology drugs with a proprietary platform.
United Kingdom
AVCT
AVADEL PHARMACEUTICALS PLC Logo
Biopharmaceutical company developing therapies for sleep disorders, focusing on narcolepsy.
United States of America
AVDL
Avalon GloboCare Corp. Logo
Develops cell-based immunotherapies and provides precision diagnostics and lab services.
United States of America
ALBT
Avidity Biosciences, Inc. Logo
Develops a class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs).
United States of America
RNA
Axogen, Inc. Logo
Develops and commercializes surgical solutions for peripheral nerve repair.
United States of America
AXGN
Axsome Therapeutics, Inc. Logo
A biopharmaceutical company developing therapies for central nervous system disorders.
United States of America
AXSM
AYTU BIOPHARMA, INC Logo
A specialty pharma company developing novel therapeutics for complex CNS diseases.
United States of America
AYTU
Azitra, Inc. Logo
Clinical-stage biopharma company developing microbiome-based therapies for skin diseases.
United States of America
AZTR
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland
BANB
Barinthus Biotherapeutics plc. Logo
Clinical-stage biopharma developing immunotherapies that guide T cells to control disease.
United States of America
BRNS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.